Cargando…
Advances in miR-132-Based Biomarker and Therapeutic Potential in the Cardiovascular System
Atherosclerotic cardiovascular disease and subsequent heart failure threaten global health and impose a huge economic burden on society. MicroRNA-132 (miR-132), a regulatory RNA ubiquitously expressed in the cardiovascular system, is up-or down-regulated in the plasma under various cardiac condition...
Autores principales: | Xu, Kaizu, Chen, Chungui, Wu, Ying, Wu, Meifang, Lin, Liming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594750/ https://www.ncbi.nlm.nih.gov/pubmed/34795586 http://dx.doi.org/10.3389/fphar.2021.751487 |
Ejemplares similares
-
Advances in Roles of miR-132 in the Nervous System
por: Qian, Yun, et al.
Publicado: (2017) -
Protective Effects of Sacubitril/Valsartan on Cardiac Fibrosis and Function in Rats With Experimental Myocardial Infarction Involves Inhibition of Collagen Synthesis by Myocardial Fibroblasts Through Downregulating TGF-β1/Smads Pathway
por: Wu, Meifang, et al.
Publicado: (2021) -
Intranasal Delivery of Targeted Nanoparticles Loaded With miR-132 to Brain for the Treatment of Neurodegenerative Diseases
por: Su, Yu, et al.
Publicado: (2020) -
miR-21, Mediator, and Potential Therapeutic Target in the Cardiorenal Syndrome
por: Huang, Cheng-Kai, et al.
Publicado: (2020) -
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
por: Nemecz, Miruna, et al.
Publicado: (2023)